Free Trial

Arteris (NASDAQ:AIP) Rating Lowered to Sell at Wall Street Zen

Arteris logo with Computer and Technology background

Key Points

  • Arteris (NASDAQ:AIP) has been downgraded from a "hold" rating to a "sell" rating by Wall Street Zen, highlighting a shift in analyst sentiment.
  • Despite the downgrade, three analysts currently hold a "buy" rating for the stock, with a price target average of $15.00.
  • Recent insider trading includes CEO K. Charles Janac selling 94,245 shares, reducing his stake by 33.18%, which may raise concerns among investors.
  • Looking to export and analyze Arteris data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Arteris (NASDAQ:AIP - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research note issued on Friday.

Several other research analysts have also recently issued reports on AIP. Rosenblatt Securities reissued a "buy" rating and issued a $14.00 price target on shares of Arteris in a research note on Wednesday, May 21st. TD Cowen increased their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $15.00.

Get Our Latest Analysis on Arteris

Arteris Price Performance

Shares of NASDAQ AIP opened at $9.97 on Friday. Arteris has a 1-year low of $5.46 and a 1-year high of $14.29. The business's fifty day moving average price is $9.44 and its two-hundred day moving average price is $8.27. The firm has a market capitalization of $425.22 million, a PE ratio of -12.16 and a beta of 1.45.

Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16,502 billion for the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Arteris will post -0.73 earnings per share for the current fiscal year.

Insider Buying and Selling at Arteris

In related news, CEO K Charles Janac sold 94,245 shares of the firm's stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.49, for a total transaction of $1,271,365.05. Following the completion of the transaction, the chief executive officer owned 189,785 shares of the company's stock, valued at $2,560,199.65. This trade represents a 33.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total value of $656,000.00. Following the transaction, the insider directly owned 9,839,071 shares of the company's stock, valued at $129,088,611.52. This represents a 0.51% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 456,043 shares of company stock valued at $5,484,028. Corporate insiders own 29.10% of the company's stock.

Hedge Funds Weigh In On Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Needham Investment Management LLC boosted its position in shares of Arteris by 2.5% in the 1st quarter. Needham Investment Management LLC now owns 2,812,500 shares of the company's stock valued at $19,434,000 after purchasing an additional 67,500 shares during the period. Franklin Resources Inc. boosted its position in Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company's stock worth $15,602,000 after acquiring an additional 142,936 shares during the period. Acadian Asset Management LLC boosted its position in Arteris by 9.6% during the 2nd quarter. Acadian Asset Management LLC now owns 987,011 shares of the company's stock worth $9,403,000 after acquiring an additional 86,288 shares during the period. Westerly Capital Management LLC boosted its position in Arteris by 14.5% during the 2nd quarter. Westerly Capital Management LLC now owns 680,000 shares of the company's stock worth $6,480,000 after acquiring an additional 85,950 shares during the period. Finally, Geode Capital Management LLC boosted its position in Arteris by 4.8% during the 2nd quarter. Geode Capital Management LLC now owns 652,754 shares of the company's stock worth $6,222,000 after acquiring an additional 30,018 shares during the period. Institutional investors and hedge funds own 64.36% of the company's stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines